The Managing Director, Mr. Krishna Prasad, is the chief promoter of Granules, bringing with him rich experience of over two decades in setting up and the management of pharmaceutical (bulk drugs) manufacturing units.

In 1984-85, he set up a small-scale unit for manufacturing of Acetaminophen/ Paracetamol that went on to become one of the largest Indian manufacturers of Acetaminophen/paracetamol and was an exporter to the US markets since 1988. Mr. Prasad, while marketing the product in US realized the potential for selling a value added version of the bulk active, known as Directly Compressible product.

Mr. Prasad had anticipated, way back in late 80's that major global pharmaceutical companies would outsource their manufacturing activities to countries like India with inherent cost advantages coupled with regulatory compliance skills and a vast pool of trained manpower.

Granules India was incorporated in 1991 with an objective of becoming a preferred outsourcing partner for major pharmaceutical companies in the regulated market and there was no looking back since then.

Mr. Prasad, as the CEO and the Marketing chief at Granules, pioneered and popularized the concept of Pharmaceutical Formulations Intermediates (PFIs) as a cost efficient and extremely convenient product for the global formulations manufacturers. These PFIs are pre-processed blends of single or multiple APIs, ready to be compressed into tablets or filled into capsules. They represent an intermediate stage between APIs and formulations and their manufacture is referred to as granulation.